These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11550935)

  • 1. Maximum of the weighted Kaplan-Meier tests with application to cancer prevention and screening trials.
    Shen Y; Cai J
    Biometrics; 2001 Sep; 57(3):837-43. PubMed ID: 11550935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An adaptive weighted log-rank test with application to cancer prevention and screening trials.
    Self SG
    Biometrics; 1991 Sep; 47(3):975-86. PubMed ID: 1742450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A group sequential test for survival trials: an alternative to rank-based procedures.
    Li Z
    Biometrics; 1999 Mar; 55(1):277-83. PubMed ID: 11318168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for sequential analysis of survival data with nonproportional hazards.
    Sooriyarachchi MR; Whitehead J
    Biometrics; 1998 Sep; 54(3):1072-84. PubMed ID: 9750253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology.
    Horiguchi M; Hassett MJ; Uno H
    Clin Trials; 2020 Dec; 17(6):597-606. PubMed ID: 32933339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of survival distributions in clinical trials: A practical guidance.
    Chen X; Wang X; Chen K; Zheng Y; Chappell RJ; Dey J
    Clin Trials; 2020 Oct; 17(5):507-521. PubMed ID: 32594788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of factorial survival experiments.
    Slud EV
    Biometrics; 1994 Mar; 50(1):25-38. PubMed ID: 8086609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Median tests for censored survival data; a contingency table approach.
    Tang S; Jeong JH
    Biometrics; 2012 Sep; 68(3):983-9. PubMed ID: 23189327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tests for homogeneity of the risk difference when data are sparse.
    Lipsitz SR; Dear KB; Laird NM; Molenberghs G
    Biometrics; 1998 Mar; 54(1):148-60. PubMed ID: 9544513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust tests for treatment comparisons based on recurrent event responses.
    Cook RJ; Lawless JF; Nadeau C
    Biometrics; 1996 Jun; 52(2):557-71. PubMed ID: 8672703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A likelihood ratio test for cancer screening trials.
    Self SG; Etzioni R
    Biometrics; 1995 Mar; 51(1):44-50. PubMed ID: 7766795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The two-sample problem with induced dependent censorship.
    Huang Y
    Biometrics; 1999 Dec; 55(4):1108-13. PubMed ID: 11315055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sample size formula for the supremum log-rank statistic.
    Eng KH; Kosorok MR
    Biometrics; 2005 Mar; 61(1):86-91. PubMed ID: 15737081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing equality of survival functions of quality-adjusted lifetime.
    Zhao H; Tsiatis AA
    Biometrics; 2001 Sep; 57(3):861-7. PubMed ID: 11550938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient estimation of the distribution of quality-adjusted survival time.
    Zhao H; Tsiatis AA
    Biometrics; 1999 Dec; 55(4):1101-7. PubMed ID: 11315054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An omnibus test for several hazard alternatives in prevention randomized controlled clinical trials.
    Garès V; Andrieu S; Dupuy JF; Savy N
    Stat Med; 2015 Feb; 34(4):541-57. PubMed ID: 25388274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weighted logrank tests to detect a transient improvement in survivorship.
    Wallenstein S; Berger A
    Biometrics; 1997 Jun; 53(2):736-44. PubMed ID: 9192461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A regression survival model for testing the proportional hazards hypothesis.
    Quantin C; Moreau T; Asselain B; Maccario J; Lellouch J
    Biometrics; 1996 Sep; 52(3):874-85. PubMed ID: 8924576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-sample statistics for testing the equality of survival functions against improper semi-parametric accelerated failure time alternatives: an application to the analysis of a breast cancer clinical trial.
    Broët P; Tsodikov A; De Rycke Y; Moreau T
    Lifetime Data Anal; 2004 Jun; 10(2):103-20. PubMed ID: 15293627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A permutation test for a weighted Kaplan-Meier estimator with application to the nutritional prevention of cancer trial.
    Frankel PH; Reid ME; Marshall JR
    Contemp Clin Trials; 2007 Jul; 28(4):343-7. PubMed ID: 17150413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.